Digital health innovations
We are actively seeking proven digital innovations that improve the health of people in the region and raise the quality, efficiency, safety and cost-effectiveness of delivering healthcare.
We are particularly interested to hear about innovations in the following categories:
  • Health maintenance - supporting people in maintaining their physical and mental wellbeing,
  • Prevention - alerting patients, carers or professionals when there are signs that things aren’t going well, and an intervention can prevent crises or emergencies
  • Access - providing more convenient and cost-effective ways for patients and professionals to interact. (e.g. remote monitoring or virtual consultations).
  • Learning and education - delivering information and knowledge to patients about their health or condition, or to professionals to support their continuous professional development
  • Pathways - providing tailored information to patients, carers and professionals on services to signpost people to the most appropriate place.  Ideally, this could be enhanced with real-time information about capacity.
  • Research - using digital tools to promote involvement in research & clinical trials, to streamline the capture of informed consent, and to capture research data more efficiently and conveniently.
  • Integration - tools that enable the secure, appropriate sharing of information between organisations (e.g. GPs and hospital clinicians) and sectors (e.g. NHS and Social Services) to allow patients to receive seamless care.
  • Data Visualisation - innovative ways of presenting information in a meaningful way to enable more informed decisions by patients and professionals.  This may involve aggregating data from different sources, reporting tools or graphic visualisations such as heat maps.

Ideas (Publish, Detailed Submission)

Innovation 'Elevator Pitch':
Sometimes it’s hard to prove impact. Risk Tracker helps organisations providing preventative services to record their work & demonstrate success. Provided free for anyone to use (under open license) Risk Tracker is for use on desktop & mobile devices
Overview of Innovation:
Risk Tracker is a powerful tool for managing clients and demonstrating outcomes. Designed to record information without getting in the way of the service you provide, it requires collection of a minimal amount of information from clients, but provides you with the flexibility to customise.
 
One of the key challenges for organisations who provide preventative services is connecting your clients’ progress with the complex range of National Outcome Frameworks. Inside Outcomes continuously maintains the policy environment to ensure that your reports will always reflect the most recent National Outcome Frameworks and, as the Frameworks evolve, we keep you up to date with the impact this will have on your day-to-day operation.
 
We have collated a database of issues that are common to preventative services. The system has been designed to support care navigation services by providing a quick tool to record client notes, measure outcomes and store files.
 
The Inside Outcomes Risk Tracker tool helps organisations to:
  • Record the common issues that clients present to services
  • Measure changes in those issues over time
  • Demonstrate the impact organisations have had in an evidence based way
  • Measure the impact organisations have had against National Outcome Frameworks
We have created a series of custom Risk Maps that reflect the issues clients commonly report, and aligned them with the public health life course. These Risk Maps cover diverse issues such as financial planning, housing and wellbeing, because we know the complexity of individual circumstances has an impact on your ability to provide services.

Our Risk Maps cover: We are also able to tailor risk maps to reflect service specific needs such as:-  
We also provide the facility to run anonymised open data reports that highlight social need in a particular area. Because we used a standardised format for recording the issues that people present we can aggregate data across multiple agencies to create a powerful, live commissioning tool.
 
We provide Risk Tracker free for anyone to use. We provide it under an open license so that you can run it in any way you want or even adapt the code for your own uses. You can access the code repository on our Github site. You can access the Risk Tracker manual here.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
Health is influenced by a range of social, environmental and economic factors which are beyond the remit of the health sector.
 
Health services, social care and housing are all focused on delivering better outcomes at lower cost to public purse and finding ways of improving the effectiveness and better understanding the value of preventative services.
 
Risk Tracker measures the impact of organisations against national outcome frameworks, supporting them to translate the things they do into the outcomes that commissioning bodies are measured against.
 
Commissioners need to identify what services are required to deliver improvements in the prevention, diagnosis and treatment of physical and mental illness in their local population, Risk Tracker provides important data to identify top priorities and opportunities for transformation.
 
It helps commissioners to identify sub groups within their population and consider service requirements across the system, creating the person-centred services patients want and need.
 
Risk Tracker is a useful tool for analysing population data and identifying those who would gain most from the services and interventions being considered, commissioners then use this information to plan, deliver and monitor services for their local population.
 
When contracting for services, commissioners are looking for positive social outcomes, which have a lasting impact with benefits for patients that can be clearly demonstrated.
 
With Risk Tracker, information is used to improve services and influence commissioning decisions. Through recording client issues in a common format Risk Tracker allows the outcomes from disparate services to be compared and contrasted. For example, the cross over in issues that the clients present to substance misuse services, mental health services and housing associations mean that data can be aggregated together.

As all data is stored in a single, secure, compartmentalised system we can create aggregated, anonymised maps of social need. The live data that can be produced records social need and is an essential tool in commissioning services against evidenced social need.
 
Investing in prevention and better health outcomes can be part of the solution to the challenges of increasing levels of need along with shrinking budgets. Effective preventative interventions can reduce health and social care costs and the need for welfare benefits. Better health can also enhance resilience, employment and social outcomes.
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
Risk Tracker helps commissioners to plan services which meet national standards and local ambitions, by combining knowledge of existing service performance and population needs.
 
Commissioners traditionally do not have access to live local data. Having the ability to extract accurate data on health and wellbeing needs for a particular area supports a flexible approach to commissioning against need.
 
The methodology that underpins our system encourages services to carry out a whole person assessment.  This means exploring the range of issues that might be present in an individual’s life. Through identifying a range of interdependent issues, services can integrate how they work around an individual and improve their outcomes.
 
An important component of planning for transformation is recognising where services may
need to be decommissioned. Risk Tracker can help to identify where less effective approaches to service delivery are to be found. With a good understanding of how a service is currently operating commissioners can identify potential opportunities for innovation and improvement.
 
With Risk Tracker commissioners can develop service specifications that focus on paying for services which produce improved outcomes for their patients, rather than reimbursing providers for activity.
 
Risk Tracker will provide commissioners with the information they need to develop a vision of future service provision that will improve the health & wellbeing of individuals and communities in the West Midlands.
 
We provide Risk Tracker free for anyone to use. We provide it under an open license so that you can run it in any way you want or even adapt the code for your own uses. You can access the code repository on our Github site. You can access the Risk Tracker manual here.
Current and planned activity: 
Risk Tracker is a cloud based system & is constantly going through development as services identify new functions. We are currently exploring developing risk maps to support refugees & asylum seekers, people with disabilities, carers & suicide prevention.

Our next significant software release will incorporate individual access to records & the ability for clients to move their records from one agency to another. We believe that a person-centred approach to improving health & wellbeing requires the ability for individuals to manage their own records.
 
We would like WMAHSN to help to scale up Risk Tracker across the WM region. It is provided free of charge under an open license & users can run it in any way they want, even adapt the code for their own uses. By using WMAHSN’s network to promote this opportunity, WM commissioners can develop service specifications that focus on paying for services which produce improved outcomes for patients rather than reimbursing providers for activity.
What is the intellectual property status of your innovation?:
Inside Outcomes own the full IP for the product but release it for use under an open source license. 
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Regional Scalability:
The Risk Tracker system has been built to be delpoyed at scale. The system can manage an unlimited number of organisations, and projects within organisations. The platform the system is built on is designed to dynamically utilise server capacity in line with the number of organsations using it. 
Measures:
The prinicple outcome we are aiming for is to be able to produce live data on social need for an area. 
Adoption target:
We are looking at opportunities to support neighbourhood working in line with strategic objectives of the West Midlands Combined Authority. The Risk Tracker system has been designed to set a basis for metrics in disaparate organisations and be used to integrate services using a common format of data collection. 
Read more
Hide details
Darren Wright 05/09/2017 - 15:35 Detailed Submission Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
Our expert people and advanced health analytics reveal insights from complex data that enable health & care professionals working across the West Midlands to make better decisions for the patients and populations they serve.
Overview of Innovation:
Sollis and the world-renowned Johns Hopkins University have collaborated to produce a population health analytics platform that helps health & care professionals transform services for patients and populations.
 
Sollis Clarity and The Johns Hopkins  ACG ®System is a person-focused case-mix system that captures the multi-dimensional nature of an individual’s health. It considers the total disease experience of each patient, including the implications of co-occurring disease, encouraging a holistic view of the patient rather than the management of specific diseases or episodes.
 
Sollis Clarity supports:
  • Case Finding - Patient level risk stratification
  • Resource Management - Case-mix risk adjustment and benchmarking
  • Population Health Needs Assessment - Population level risk stratification
  • Fair Shares Budgeting - Capitated budget setting
 
Sollis Clarity delivers robust business analytics and data management to identify and analyse populations across the continuum of care to help health & care providers and commissioners get a precise understanding of patterns of mult-morbidity across populations and its relationship to utilisation, costs and outcomes.
 
Sollis Clarity delivers insights into the morbidity patterns of different populations, supporting population health management, service transformation, integrated care and, ultimately, better outcomes for patients.
 
Sollis Clarity goes beyond patient level risk stratification. Risk stratification at a population level helps the health economy — providers and commissioners — analyse and minimise the progression of diseases and the exacerbation of co-morbidities. When combined with the ACG System it is a comprehensive family of measurement tools designed to help explain and predict how healthcare resources are delivered and consumed.
 
Sollis Clarity provides the evidence base to support:
  • Planning and service re-design
  • Clinical decision making
  • Outcomes-based commissioning
  • Risk stratification and predictive modelling
  • Population profiling / segmentation
  • Case-mix adjusted benchmarking
  • Integrated multi-disciplinary care
To view Sollis - Nigel's Story - click here.
To view UK Healthcare data analytics for NHS CCGs - click here.
To view The Proactive Care at Brighton & Hove - click here.
To view Population Profiling at NHS Slough CCG - click here.
To view Using Data to Gain Greater Insight - click here.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wealth creation / Digital health
Benefit to NHS:
Population health analytics delivers an evidence base (insights from data) that supports large scale health & care service transformation. It is an essential component of any Population Health Management strategy and as such underpins the journey to a fully fledged Accountable Care System (ACS).

The Sollis Clarity health analytics platform is a modular system with mix-and-match components to help you achieve your healthcare analysis and commissioning/budgeting requirements.
 
Population health management helps Health & Care stakeholders identify and quantify the drivers and outcomes for addressing the needs of local populations.
 
Led by directors with decades of NHS experience, Sollis analytics software and professional services have been used to analyse data on nearly half the population of England. We believe patient-centred care strategies based on the needs of local populations provide the key to better population health management.
 
Sollis Clarity is helping several CCGs in the UK to implement new reporting and service planning initiatives.  To view examples of ‘Service Transformation: Stories from the CCG Frontline’ summarising how CCGs are using the insights provided by Clarity Patients and ACG® System analysis for service planning and transformation – click here.
 
The Sollis Clarity health analytics platform has two distinct but complementary solutions — Clarity Patients and Clarity Finance — address population health management and financial analysis respectively.
 
Clarity Patients, combined with the Johns Hopkins ACG® System, provides a comprehensive family of measurement tools that helps explain how healthcare resources are delivered and consumed. It supports new commissioning models such as Commissioning for Value, Outcomes Based Commissioning and Year‑of‑Care Commissioning. It delivers analytics that provide insights to support health & care interventions and innovation and it will help you track the success — or otherwise — of those innovations over time.
 
Clarity Finance provides contract management and activity costing with multiple tariffs, giving you business critical evidence on which to base commissioning decisions. It enables you to store and compare different versions of cost and volume type tariffs as well as non-activity tariffs, such as year of care or outcome based currencies, to give you insights on the most effective commissioning decisions.
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
Knowledge of the risk profile of the region’s population (based around a population segmentation approach) will help Health & Care stakeholders across the West Midlands commission and deliver appropriate preventative services that will drive positive health outcomes for the 'at need' populations of the West Midlands. 

Through the innovative use of information technology to identify patients most in need of an intervention (impactable patient cohorts) Sollis Clarity helps to identify patients who could most benefit from earlier, better informed health care interventions.
 
The Sollis population health analytics platform allows the patient population to be risk assessed to provide timely, evidential data to all members of a Multi-Disciplinary Team (MDT), to include clinicians but not limnited to them. This enables MDT members to provide focused levels of care to specific groups of patients, reducing the risk of a patient’s condition worsening due to it being identified early so assisting MDT members in identifying and improving the care of at-risk patients.
 
Much can be achieved through the acquisition of primary care, secondary care, community care, mental health, prescribing and social care data. It can provide a rich understanding of how healthcare resources are delivered and consumed and by whom. Such analysis can aid an understanding of whether scarce resources are being deployed to those population groups in greatest need.
 
It is important that any population health analysis should focus not on single disease conditions, but on the burden of multi-morbidity observable in a local population.  Population health programmes that have the best chance of success will be those that demonstrate an understanding of the importance of multi-morbidity and its impact on the local health and care economy.
 
Using data to identify early healthcare interventions can provide significant benefits to patients, particularly those with long-term conditions. Providing the functionality to make real time decisions based on clinical evidence will improve outcomes for patients.
 
Sollis exist to help our customers deliver better patient outcomes, better patient experiences at an affordable cost and are wholly focused on the delivery of insights that will help deliver a sustainable and transformed health and care system in the West Midlands.
Current and planned activity: 
We are currently providing analytics support to thirty (30) plus Clinical Commissioning Groups (CCGs) nationally as well as nine hundred (900) plus GP practices and a number of NHS Vanguards, principally Multispecialty Community Providers (MCPs).

We would like to engage with health and care professionals involved in the development and evaluation of New Care Models throughout the West Midlands who want to use evidence based data to understand patterns of multi-morbidity and its relationship to utilisation, costs and outcomes. We are particularly interested in engaging with Sustainability & Transformation Paernerships (STPs) and emerging Accountable Care Systems (ACS).
What is the intellectual property status of your innovation?:
Sollis owns all Intellectual Property (IP) for the following software applications:
  • Sollis Clarity (Population Analytics Platform)
  • Sollis Clarity Patients
  • Sollis Clarity Finance
 Johns Hopkins Health Care (JHHC) owns all Intellectual Property (IP) for the following software:
  • ACG® System
 Also:
  • ISO9001
  • IG Toolkit Certified
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
3 years +
Ease of scalability: 
2
Read more
Hide details
Nigel Slone 21/08/2017 - 10:53 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
Achiever Medical LIMS helps research institutions to improve lab efficiency, facilitates return on investment into sample collections & demonstrates compliance to legislation. Inbuilt security protects patient identifiable data with controlled access
Overview of Innovation:
With increasingly stringent regulations and greater emphasis on profitability placed on laboratories, Achiever Medical LIMS was designed in conjunction with leading scientists & clinicians to provide an easy-to-use sample management system incorporating sample tracking, clinical data management, workload & communication management. The system addresses the gap left by traditional LIMS systems by providing enhanced donor and research profile data.
 
Achiever Medical LIMS is a process driven & web browser-based laboratory & clinical data management system that is flexible/scalable to evolve as needs develop. Using Open Standards to streamline the sharing of information across existing applications Achiever Medical LIMS allows data to be imported from, e.g. Patient Information & Storage Environment Management Systems, Lab equipment, Emails & Calendars for an holistic overview of samples, equipment, environment & workload.
 
Achiever Medical LIMS enables the mapping of Standard Operating Procedures (SOP) to ensure staff adhere to agreed standards, ensuring regulatory compliance & promoting quality, efficiency & consistency. Achiever Medical LIMS can assist in compliance with the Human Tissue Act, Good Laboratory Practice & CFR 21 Part 11.
 
Sample tracking functionality delivers complete traceability with automatic generation of unique reference numbers for each sample. Core sample details e.g. location/sample type are tracked as values change for a complete audit history. Sample profile information is captured including sample & tissue type, tissue collection details and associated patient & project information. Barcode labels can be generated for single/multiple samples & customised information can be contained within each label. These labels can be scanned to facilitate rapid sample retrieval.
 
Achiever Medical LIMS integrates data and processes across multiple faculties/diverse into a single solution. This enables authorised users to gain an holistic oversight, having full access to complete donor/patient records. Robust security filters and flexible tools within the LIMS allow the creation of custom levels of user security access to samples, donors or project information. This flexibility is especially useful for biobank or bio-repository management or when conducting multiple studies/clinical trials/projects with multiple collaborators. These tools support collaborative working and simplify a task that can otherwise be legislatively difficult and time-consuming.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Advanced diagnostics, genomics and precision medicine / Clinical trials and evidence / Digital health
Benefit to NHS:
Achiever’s LIMS ability to quickly and efficiently organise samples for tracking, storage and retrieval, enables the full economic and scientific value of existing samples to be effectively realised and more efficient processing of sample requests and tests.
 
Achiever Medical LIMS enables sample aliquots to be easily generated from the parent record for complete traceability with a sample ‘family history’ view available, from both the parent & child records, allowing rapid navigation between samples within the same family.
 
Tools to enable the detailed tracking & monitoring of a sample via comprehensive sample location & check in/out auditing are provided. These include recording each time the sample is removed from its location, who checked it out and for what purpose. Samples that have been ‘checked out’ are easily identifiable and can be quickly ‘checked in’ when required along with their full audit trail information.
 
Samples used and associated stock depletion during testing or analyses are automatically flagged with Achiever Medical LIMS.
 
Composite samples such as Tissue Microarrays can be easily created within Achiever Medical LIMS, with each individual sample’s position within the composite sample recorded, any requests for removal can be easily and effectively managed.
 
External sample requests received by biobanks & bio-repositories can be managed through Achiever Medical LIMS using its built in management protocols. This facility provides staff with complete chain of custody details for each sample ((the person who requested the sample, reason for request, who approved the request & expected return date (if required) are captured)). Rejected requests are appropriately managed with reasons for rejection being recorded. Where only part of the sample is required, aliquots can be generated for the required amount along with accompanying complete family history record. Dashboards highlight samples due for return, allowing staff to monitor/chase up samples where required.
 
Achiever’s complete sample auditing & sample tracking functionality records changes by staff to core sample information. Audit trail information includes details of specific information fields changed, values pre & post change, date, time and name of the user who made the change etc. Chain of Custody details, including who checked in the sample, to whom it is checked out (where relevant), storage location, details of processing and projects included in are also captured.
Initial Review Rating
4.20 (1 ratings)
Benefit to WM population:
The West Midlands population has access to the most extensive range of specialist tests from a range of stakeholders, showcasing the potential of laboratory contributions to raise the profile of the research, clinical and diagnostic expertise of the region’s NHS laboratory staff.
 
For laboratories, biobanks and bio-repositories sample tracking & donor management capabilities are of huge importance in donor profiling, consent management, traceability, chain of custody & regulatory compliance.
 
The integration of a potentially region-wide system to manage tissue tracking across multiple teams, hospitals and sites can avoid duplication of data entry and maximise data quality while working within the IT and legislative constraints imposed by disparate working environments of the users.
 
Having sought approval for sample collection, samples need to be treated in line with SOPs and available for use in research both internally and with permitted collaborators.  Utilisation of samples is important to maximise the potential benefit from the donor and to make best use of the resources available to clinicians and researchers.  Cost recovery models allow for income generation to promote the sustainability of the biobank.
 
Improving the value of data quality enables laboratory staff and researchers to search for tissue samples from specific cohorts of donors, filtering by level of consent given by donors, allowing them to search for tissues that have not opted out of specific elements of research. This level of capability will allow biobanks and bio-repositories to service very specialist research requests, increasing value.
 
The quality of the donor, consent, storage and tissue viability data greatly increases the value of the tissues to laboratory staff and researchers. Once cleansed, Achiever Medical LIMS’s storage management capabilities help to increase levels of utilisation, reducing overhead costs per sample.
 
The ‘Achiever Medical Researcher Portal’ allows authorised collaborators to view restricted data for relevant samples.  This external view portal promotes the management of sample requests all within a single system, giving an easy means of sharing samples and the relevant data.  Automatic alerts ensure applications are managed efficiently.
 
In addition, reports and analysis providing real-time data, can be run at the touch of a button instead of valuable laboratory personnel spending days (sometimes weeks) painstakingly collating information from various spreadsheets.
Current and planned activity: 
We are a West Midlands based company wishing to work with our regional health providers.  
 
Our current users include Leeds (LTHT), Nottingham (NUH) and Cambridge (CUH) Trusts all of whom use the system to manage their research samples, donor data and to support HTA Audits.
 
Both NUH and CUH use Achiever Medical as part of their involvement with GEL.
 
Achiever Medical is being used to pioneer the data standards being promoted by UKCRC.
 
We would like to work with WMAHSN who are leading the collaboration of The West Midlands Genomic Medicine Centre (WMGMC), a partnership of 18 NHS Acute Trusts across the region, working collaboratively to help to deliver the UK 100,000 Genomes Project.   
We would welcome the opportunity to discuss any requirements for sample management and donor management, projects and disease specific systems for either single organisations or multi-institutional requirements.
What is the intellectual property status of your innovation?:
All IP is owned by Interactive Software Limited.
Return on Investment (£ Value): 
medium
Return on Investment (Timescale): 
2 years
Ease of scalability: 
Simple
Read more
Hide details
Sandie Shokar 01/08/2017 - 08:19 Publish 2 comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
Virtual Teleconsultations for LTC management 
Overview of Innovation:
Hailadoc is a cloud-based secure clinical communication system that 
enables health professionals to connect, communicate and collaborate with patients virtually ( web/app based system) through messaging, file/ photo/ image sharing and video chat. Hailadoc was designed and developed by a team of clinicians with business and technical experts. 
 
The Vision
 
The Hailadoc vision is to enable a virtual outpatient experience so that patients receive care whenever possible through their mobile phones. The problem in healthcare which Hailadoc helps to solve is inefficient care due to unnecessary clinic appointments requiring in-person hospital attendance. Many appointments for “routine follow up” could be avoided if clinical advice was communicated to patients at home via their mobile phones or computers.

Value Proposition

Advances patient centred care:
Provides readily accessible communication channel between health professionals and patients
Continuous connection with patients to ensure patients follow treatment plans
Facilitates closer medication management
 
Increases access to care:
Brings healthcare to those who find it difficult to travel
Enables providers to deliver quality care at a lower cost
Reduced travel costs for patients and health professionals
More efficient patient load management for health professionals
Timely monitoring of patient in the community
 
Reduced unplanned hospital admissions
Improves treatment compliance through faily monitoring and earl care tream intervention
Increase chance of addressing problems before becoming acute

Benefits
Older person and informal carers
  • Enables independent living in own home for longer
  • Peace of mind for both informal and professional carers
  • Supports daily routine decision making for better patient management
  • Greater sense of safety, security and comfort enabling older people to feel in control of their lives
 
Health and Care commissioners
  • Optimises outpatient clinic utilisation for new patient consultations and complex patients 
  • Routine monitoring and timely response decreases acute hospital admission
  • Supports integrated care plans
  • Reduces cost of care through fewer home check visits.
  • Reduces length of inpatient admission by facilitating speedier hospital discharge,
 
Information Governance
We are in the process of certifying as NHS IG Toolkit Compliant Level 2
Our current track record within the NHS has involved clearing Information Governance at 2 large NHS trusts.
Data encryption meets NHS data security standards
Stage of Development:
Close to market - Prototype near completion and final form may require additional validation/evaluation and all CE marking and regulatory requirements are in place
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Digital health / Innovation and adoption
Benefit to NHS:
Reduces the number of face-to face consultations - Reducing cost
Reduces the need to use follow up consultations for clonica space- increasing the throughoput of first consultation aand therefore lowering RRT / increasing percentage of patients meeting RTT standard                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
Initial Review Rating
4.20 (3 ratings)
Benefit to WM population:
Teleconsultations is becoming increasingly established as the future for consultation practice. It is recognised that a large proportion of follow up care ( which makes up 70%) of outpatient appointments, does not require face-to-face engagement. A secure communication channel  between doctors and patients to share discuss on going management will ensure aptients are provided wiith a more accrate 
Current and planned activity: 
We are currently in discussion to deliver an asynchronous teleconsultation service at a leading London hospital .
Return on Investment (£ Value): 
medium
Return on Investment (Timescale): 
2 years
Ease of scalability: 
2
Read more
Hide details
Nina 13/07/2017 - 15:11 Publish 1 comment
0
0
Votes
-99999
Innovation 'Elevator Pitch':
Alamac work in partnership with health and social care organisations / systems to help diagnose challenges in real-time, identify key actions based on objective data, and implement changes which result in sustainable improvement.
Overview of Innovation:
Alamac are specialists in behavioural change and sustainable performance improvement. We apply a simple process, using a proven clinical method, and combine this with our technology to create sustainable change.

We work with our partner organisations to understand the flow of patients through different pathways of care - including acute / hospital care, community health, primary care and social care. We work alongside teams to gather relevant, current data and act upon it.

We develop the individuals and teams to use this data as information to drive action. Teams are able to identify the 'cause and effect' of pressure points and actions are then put in place to improve the system performance, the patient's journey and quality outcomes.

Our team bring a wealth of experience in clinical practice, operations management and senior leadership. 100% of our delivery team are clinically or NHS trained leaders with the experience, skill and credibility to deliver. They bring their experience and knowledge of working with over 45 systems/organisations across the NHS and Social care. We act as a critical friend, helping teams to think differently and create a disciplined culture of real-time improvement.

We deploy a simple process based around the transparency of daily data. Through our facilitated ‘Test and Learn Cycles’, daily use of this intelligence involving senior leads from across the system allows teams to diagnose system issues in real time, and use objective information to identify actions to tackle these issues.

Our approach creates a fundamental change in the way teams work. It supports collaboration and integration across organisational boundaries. Our process allows teams to work on objective intelligence and reality, rather than emotion and myth. We create a disciplined culture of support rather than blame and of action rather than story. Our encouragement of predictions means that teams drive the changes they want to see and become less reactive. This delivers a greater grip on the issues at hand, removes uncertainty and drive proactive actions.

By following our process every day, consistently and persistently, we create lasting culture change.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Wealth creation / Digital health / Innovation and adoption
Benefit to NHS:
  • We deliver transparency of information across all parts of the organisation/system- providing ‘One Version of the Truth’ that is used daily to form actions to deliver benefit.
  • We use daily forums to fix 'in-day' problems and to monitor systemic solution delivery. During this period we help teams to identify and collate measures, understand what targets they want to set, and begin to take earlier and better decisions to deliver incremental improvement.
  • We help teams to develop a system and a forum to share intense and constructive feedback, as well as a new numerate language to drive a culture of real-time improvement.
  • The process supports individuals, teams and organisations to hold to account based on objective information.
  • We develop and coach individuals and teams in improvement methodology to deliver sustainability to the organisations and system
The outputs are:
  • Integration of and patient pathway improvement and service reconfiguration
  • Rebalance of capacity and demand (management)
  • Stabilisation of operational performance to build recovery and resilience
  • Construction of associated programme management and governance
  • Deliver in excess of 10x ROI – 30% of which is cost saving
  • Leadership development and empowerment of front line leaders and senior and executive teams
  • True ‘clinical team to board’ transparency, reporting and assurance.
  • Trained and skilled workforce in continual improvement
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
Through our simple process, clinical method and technology we can support the WM to deliver improved and sustained performance; integration and collaboration and a skilled workforce in improvement methodology. Some examples our outlined below:

DTOC Reduction
In a medium sized health and social care system, a key issue impacting on patient flow was identified as underutilised capacity within the community hospitals.

We developed a key set of measures to enable a better understanding of the ‘cause and the effect’ of the underutilised capacity and supported the teams in identifying and implementing appropriate actions.

The result of the approach was an increase in community bed utilisation. The effect of this was a reduction in the number of medically fit patients in the Acute Hospital.




Improving Quality
Working with the frontline teams delivering patient care, we support them to analyse their own data, take ownership of it and develop the confidence to use and make decisions based upon it. The staff and teams feel empowered to identify and implement actions that they can monitor, in real time, to ensure actions are having the intended effect.

In one ward we identified that 45% of their falls were occurring on a Sunday.

Through working with the ward to diagnose the ‘cause and effect’ of this number the ward sister adjusted her roster (at no additional cost) to ensure a dementia champion was on duty on a Sunday.

This resulted in the number of falls on a Sunday reducing to 0 which was sustained.


By impacting on quality outcomes, such as falls, there has been a cost saving associated for our clients. The average cost of a fall to an acute hospital is £3000, (The Kings Fund, 2013).

A client example:


Releasing Time to Care
In one of our clients we were able to capture key measures required for ‘Audits of Key Performance Indicator Bundles’ at the front line, and in real time, as part of the daily standard work.

Prior to this, the audits were being completed by a clinician in each team taking 1 day a month in 21 teams away from clinical care.

We enabled the staff to rapidly complete the audits as part of the daily routine releasing clinical time back to the teams. It also released time in the governance team as the manual process was no longer needed.

The clinical time saved has been costed as:
1 day/month for 21 teams = 252 days/year
Costed at midpoint Band 5 = £24,211 savings/year
Current and planned activity: 
Alamac would like the opportunity to work with healthcare providers in the West Midlands, as well as work more closely with the West Midlands Patient Safety Collaborative, hosted by the WMAHSN, that aims to improve safety and continually reduce avoidable harm by supporting organisations in working together to develop, implement, share and spread proven safety interventions that are based on rigorous, evidence-based scientific methodologies.
What is the intellectual property status of your innovation?:
Our improvement methodology - simple process, clinical method and our technology is the intellectual property of Alamac
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
1 year
Ease of scalability: 
2
Read more
Hide details
Sarah McGovern 06/07/2017 - 12:55 Publish Login or Register to post comments
6
1
Votes
-99999
Innovation 'Elevator Pitch':
Coordinate high quality palliative care.
Overview of Innovation:
Patients reassured their urgent care plan preferences are shared with appropriate health professionals after Epro develops End of Life care plans for a Global Digital Exemplar.

The challenge

The final stages of life with a terminal illness can be a lonely and anxious time. Healthcare professionals provide as much support as possible, and it is essential that top class specialist palliative care spans hospitals, community and hospices. Faster, more effcient ways to coordinate high quality end of life care are required for the growing number of people in need of specialist palliative care.

NHS England says recording patients’ wishes around the last days of life, and making them available to medical staff and carers is vital for patient experience improvements. To achieve this, one Global Digital Exemplar (GDE) embarked on a project to record this information digitally and make it available in a standardised, easy-to-access way.

The solution

The GDE NHS trust wanted to record End of Life care preferences and make them available throughout its hospital and in the community. The trust asked Epro to design and implement a standalone solution which linked the End of Life care plan to the current installed Epro system.

The document is updated by staff throughout the patient’s admission in hospital and records information such as an individualised care plan, a hospital escalation plan, advice for community care, information about medication and discharge. The notes are available for medical staff to action, anywhere and anytime in the hospital. The End of Life note integrates with, and can be automatically distributed with the discharge summary to the GP. 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
Results

The End of Life note functionality was developed by Epro within just four months. This followed a user-centred approach with several iterations of testing and design enhancements to ensure it met the requirements of clinical users. The solution delivers the following benefits: 
  • Patient preferences accessible throughout the hospital regardless of department or specialty
  • Time savings for staff searching for patient preferences and information
  • Information about End of Life preferences available on re-admission
  • Distribution of appropriate information to the GPs via the discharge summary
  • Flexibility in information collection, avoiding delayed discharges
  • Information can be collected at different times during an admission
  • Local con guration of information fields reduces risk of loss, and supports carrying forward relevant data, whilst tracking and updating user preferences such as language choice
  • Audit and monitoring – ability to review a list of patients discharged without completed forms, or missed review dates
  • Seamless integration to existing EPRs, meaning users do not have to log in twice 
Initial Review Rating
3.00 (1 ratings)
Benefit to WM population:
Results 

The End of Life note functionality was developed by Epro within just four months. This followed a user-centred approach with several iterations of testing and design enhancements to ensure it met the requirements of clinical users. The solution delivers the following benefits: 
  • Patient preferences accessible throughout the hospital regardless of department or specialty 
  • Time savings for staff searching for patient preferences and information 
  • Information about End of Life preferences available on re-admission 
  • Distribution of appropriate information to the GPs via the discharge summary 
  • Flexibility in information collection, avoiding delayed discharges 
  • Information can be collected at different times during an admission 
  • Local con guration of information fields reduces risk of loss, and supports carrying forward relevant data, whilst tracking and updating user preferences such as language choice 
  • Audit and monitoring – ability to review a list of patients discharged without completed forms, or missed review dates 
  • Seamless integration to existing EPRs, meaning users do not have to log in twice
Current and planned activity: 
EoL currently implemented in one NHS Trust with Global Digital Exemplar Status (GDE) 
 
The trust already uses many of our solutions and wanted to extend its capability with easy access and an audit trail of the agreed care plan with the patient to help medical staff ensure the highest standard of care by putting patient wishes first.”

Dr Francesca Leithold, Head of Professional Services, Epro
 
Access tailor-made clinical software

We have a strong history of designing bespoke software solutions that meet NHS trusts’ speci c clinical work ow, electronic document management and interoperability challenges.

Get in touch to see how our development team, led by a former clinician can help you today. 
What is the intellectual property status of your innovation?:
Epro holds all rights to the EoL intellectual property   
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
2
Read more
Hide details
Keli Shipley 04/07/2017 - 10:38 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
Complicated and laborious document production processes become easier to manage through intelligent workflow software that remembers and organises information with built-in reporting to manage production targets.
 
Overview of Innovation:
Epro Scrik is a third generation dictation, forms and documentation management mobile technology solution, designed by clinicians.
 
The solution uses a unique combination of structured data, dictation, templating, speech recognition and usability to revolutionise clinical correspondence and document production workflows for clinicians saving time and money. 
 
Scrik then leverages these a second time to enable clinicians to access and search patient documentation and notes quickly, presenting information in the fastest, most convenient way possible.
 
Complicated and laborious document production processes become easier to manage through intelligent workflow software that remembers and organises information with built-in reporting to manage production targets.
 
The solution is fully interoperable and very flexible. It can enhance legacy EPRs and integrate with legacy PAS systems. It can be combined with Epro’s wider group of clinical functionality for clinical workflow, patient journey and document management to help NHS trusts improve patient safety, increase efficiencies and achieve a paperlight working environment.
 
 
With Epro Scrik, you can:
 
  • Create templated clinic letters with just five clicks.
 
  • Make more informed medical decisions with greater access to current and historical information
 
  • Reduce risk of clinical errors by facilitating more legible, complete and accurate information
 
  • Meet your document delivery targets through faster letter production
 
  • Make better use of staff time and skills by removing or automating repetitive tasks
 
  • Save money on paper, printing and postage
 
  • Improve coordination and correspondence with other care providers, such as GPs
 
  • Increase clinical efficiency with speedy, consistent access to patient information at the point-of-care
 
 
 
Core features:
 
  • Capture clinical information with industry leading digital dictation, speech recognition and snippet technology
 
  • Enable mobile working for clinicians
 
  • Chronological view of historical patient information
 
  • View, manage and schedule clinic appointments
 
  • Integrate with / record SNOMED coded patient allergies information
 
  • Full visibility of patient admissions, transfers and discharges
 
  • Safeguard patient information by specialty or department
 
  • Electronically distribute documents to GPs and other care providers
 
  • Powerful reporting functionality
 
Links seamlessly with patient administration systems Import ad hoc documents 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Wealth creation / Digital health / Patient and medicines safety / Person centred care
Benefit to NHS:
Video case study: Transforming clinical correspondence performance at Taunton and Somerset
Watch the video here: youtube.com/watch?v=uCJpF86jslo
Anticipated outcomes:
 
Epro worked with Taunton & Somerset NHS Foundation Trust to transform its clinical correspondence. The trust reported improved patient experience (due to speedier communication), decreased stress among staff, faster clinical access to patient letters, reduced clinical errors, and compliance with audit and access requirements.
  • £1.1m of secretaries’ and clinicians’ time
  • £11K on administrative costs £4.3K spend on printing
  • 96% reduction in letter transcription backlog
  • 100% compliance with 7 day letter delivery CQUIN

£4.3K spend on printing
Initial Review Rating
4.60 (1 ratings)
Benefit to WM population:
We are launching a telemarketing campaign on the 6th June across the West Midlands offering a FREE of Charge Paperlight Clinic to any NHS Trust in the West Midlands.
Current and planned activity: 
We are launching a telemarketing campaign on the 6th June across the West Midlands offering a FREE of Charge Paperlight Clinic to any NHS Trust in the West Midlands.
What is the intellectual property status of your innovation?:
IP is with Epro only
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Read more
Hide details
Keli Shipley 04/06/2017 - 21:43 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
Crowdsourcing the most appropriate referrals to improve pathways and promote integration. Using whole person assessment to enable to agencies to work together more efficiently around an individual. 
Overview of Innovation:
Referral Tool app has been designed to quickly identify local organisations that you can refer clients to. It’s been created to complement any data system you use, entirely focusing on improving the quality of referrals.

The system works through carrying out a brief whole person assessment. This involves talking to the client and trying to assess the full range of issues that they are looking for help and support with. Using our simple Risk Maps these issues can be quickly recorded.

Both clients and workers are presented with a succinct list of appropriate referral agencies for the issues identified. Through creating a holistic approach to providing help and support agencies can tackle those complex issues that require joint working, therefore, improving outcomes. 

We have created this to be used across a local area with all of the organisations using it to crowdsource the most effective agencies to help resolve problems. As agencies understand the issues they are best placed to resolve they can manage which clients are referred to them. This dispersed system of management means no one agency is required to keep data up to date. As a result, this is a sustainable system created to reduce central management costs. 

Every agency can customise the system to reflect the sort of issues that their clients present. Which means the assessment process is simplified to focus on the things that are most important to the person in front of you and can be carried out in a matter of minutes. 

Designed to focus on services such as social prescription or community navigation, Referral Tool can be easily used by any agency that carries out face to face client work. 

As all issues raised are recorded in the same format, Referral Tool also generates open data reports to identify patterns of social need in an area. This can be used to inform commissioners on where the most pressing commissioning needs are. 

Referral Tool is released under an Open License for anyone to use in any way that they want.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Digital health / Person centred care
Benefit to NHS:
As many people present to service with complex issues it is rare that a single agency can resolve all issues. Where issues are interdependent on each other then it is essential that agencies work together coherently to support an individual. Referral Tool provides an easy method  to identify relevant local agencies and how to make a referral.

This avoids many of the problems of service directories as there isn't a need to keep the referral data up to date, this is manged by agencies. It also does not require someone looking for referral agencies to second guess how to search for agencies 

As all data is collected in the same format Referral Tool can also produce geographical maps of need to demonstrate where commissioning priorities should be set. 
Initial Review Rating
3.40 (1 ratings)
Benefit to WM population:
The WM population benefit on a number of levels. More integrated services mean that they do not have to seek help from a wide range of sevices. A seamless referral process is less likely to discourage people from taking up services they are offered. 

As Referral Tool can generate live data on local need then commissioners have an evidence base for how they can target services to address local need. 
Current and planned activity: 
We are currently using Referral Tool across Sandwell but this is voluntary sector promoted activity rather than via the NHS. 
What is the intellectual property status of your innovation?:
We own the intellectual property of our Referral Tool product but make it available to anyone under an open license.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Regional Scalability:
This tool can be easily scaled across the West Midlands region. We are in the process of rolling it out across Sandwelll. The Sandwell roll out has been fully funded and can be used by anyone in that area. For the best outcomes the tool functions in local authority areas in order to ensure that referrals and pathways are most appropriate to clients and patients. 
Measures:
We are guaging success by measuring penetration within face to face services where the tool is being implemented. This can be easily measured through the way the tool creates open data maps of social need in a given area. 
Adoption target:
We are looking to implement the Referral Tool in each local authority area in the West Midlands. 
Read more
Hide details
Darren Wright 16/05/2017 - 15:49 Detailed Submission Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
Levo® Therapy System is an innovative sound based therapy designed for use during sleep. The system creates and delivers a personalised sound therapy that uses the brain’s natural plasticity to reduce symptoms and provide relief long term.
Overview of Innovation:
Tinnitus is a conscious awareness of a sound in the ears or head that is not due to an external noise. Every individual has their own very personal tinnitus tone. It can be a high or low frequency sound and its volume can vary over time. An estimated seven million people in the UK have experienced tinnitus at one time or another.
 
People living with tinnitus report that their condition limits their social life, their relationships and their opportunity to work (source: British Tinnitus Association patient website https://www.tinnitus.org.uk/).
 
Levo® Therapy System for Tinnitus is an FDA cleared and CE approved sound-based therapy which works with the brain’s natural plasticity to help the brain to get used to, or habituate, to the tinnitus sound within the hearing centre of the brain.
 
Levo® is specifically designed to be used during sleep when our brains are more prone to be responsive to sound therapies that strive to change brain activity patterns. The system enables patients to map their specific tinnitus sound, or ‘sound print’, to create a personalised sound therapy.
 
The personalised therapy sound is presented to the patient while they are asleep via an iPod device using a tailor-made proprietary ear phone system which is designed to be slept in (Levo® will switch itself off automatically during the night once the correct dosage has been applied). This stimulates the hearing centre of the brain with the goal to encourage habituation to the tinnitus sound and reduce the perceptual loudness / annoyance of the tinnitus signal. Improvements in tinnitus symptoms are tracked over time, which is motivating for the patient and provides useful guidance for the clinician.
 
The Tinnitus Clinic is suitable for patients with atonal or tonal tinnitus, or a mix of frequencies from less than 200Hz right through to beyond 10,000Kz. Levo® System therapy is a prescriptive approach which requires a single course of treatment over a period of 30-60 days.  Patients self-administer Levo® therapy during their night time sleep cycle and can carry on their normal daily life without disruption, including wearing hearing aids for hearing loss during the day if required.  Attendance at a clinic for follow up visits is usually one or two visits only.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Digital health
Benefit to NHS:
Currently NHS management of patients with tinnitus can require clinic & GP attendance over a period of years alongside self-management techniques with treatment involving devices (hearing aids/sound generators) & counselling strategies aimed at reducing the negative emotional impact of the condition.
 
The Levo Therapy System provides a prescriptive pathway of treatment delivered by audiologists or hearing aid dispensers reducing the need for a multidisciplinary approach & freeing up time for healthcare professionals (GP's/audiologists/psychologists). Successful treatment with Levo Therapy would mean patients do not need to revisit GP/audiology/ENT services. It also has the additional effect of improving the patient’s emotional state without the need for psychodynamic intervention/pharmacotherapy delivering a cost saving advantage for the health service.
 
Using the NHS Reference cost schedule 2010-11 the conceptual (comparator) & the intervention (Levo Therapy model) have been costed.
 
An average patient receiving Levo Therapy will receive the device once in their lifetime at which point their tinnitus is managed & does not return, i.e. successfully habituates. The cost of the Levo Therapy pathway in the private sector is currently £4225 over a patient’s lifetime.
 
In comparison when looking at the average cost of the comparator arm of the technology which is the usual pathway for NHS tinnitus treatment, the weighted average lifetime cost per patient for these individuals is £8414.
 
Therefore for patients with a THI level 3 & above Levo Therapy generates savings of £4189 per patient when comparing NHS costs to private sector costs that include the service, fitting & follow up charges.
 
The weighted average cost is based on the multitude of resources required to manage tinnitus under the comparator technology over a patient’s lifetime such as:
  • Most patients require 2 digital hearing aids which need to be replaced every 5 years at a lifetime cost of about £1200 per patient, cost includes an assessment & fitting for each replacement
  • Digital hearing aids require continuous follow up appointments/repairs at a lifetime cost of about £4300 per patient
  • Most patients using hearing aids won't have their tinnitus managed & therefore will require a session of MTRT or CBT at a lifetime cost of about £580-£1200 respectively per patient per treatment
  • Once MTRT &/or CBT are successful patients will require counselling to sustain their tinnitus treatment at a lifetime cost of about £2533 p
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
Hearing is central to our health & wellbeing. Hearing problems are a growing challenge across society & will become even bigger over the next decade due to the growing ageing population & increased exposure to workplace & social noise such as MP3 players.
 
It is estimated between 10-15% of adults will have tinnitus with 3% likely to require a clinical intervention for their tinnitus*. Reported prevalence of tinnitus varies from 12-36% & is more common in children with hearing loss compared to children with normal hearing. Like adults most children self-manage but a proportion require further support.*"
 
In some sections of the population tinnitus is statistically more significant for example 11% of veterans that were surveyed reported having problems hearing & 6 % reported tinnitus.**
 
Statistics show a higher incidence of tinnitus amongst UK Armed Forces than the general population^ & with the Royal Centre for Defence Medicine located at University Hospitals Birmingham NHS Foundation Trust & the HQ of the Surgeon General & the Joint Medical Command in Lichfield the regions Service community could benefit from access to the Levo Therapy System.
 
According to the Department of Health (2011) mental health problems are the largest single source of disability accounting for 23% of the total disease burden.*** The innovative ‘RAIDPlus integrated mental health urgent care test bed’ project highlights the region’s commitment to providing services for people with mental health illness.
 
Tinnitus is associated with a higher occurrence of depression than the general population (Holmes and Padgham 2009). Daugherty (2007) suggests at least 40-60% of patients with tinnitus also have a major depressive disorder, which often worsens their perception of the condition.***
 
For patients with tinnitus who have a depressive disorder The Levo Therapy System can improve emotional health & in turn the patient’s quality of life whilst reducing the burden on the health system.
 
* Davis, A, El Refaie, A (2000) “The epidemiology of tinnitus” in R Tyler (ed.) The Handbook of Tinnitus. Singular, pp 1 -23
** The Royal British Legion Household Survey 2014, November 2014.
https://www.actiononhearingloss.org.uk/supporting-you/policy-research-an...)
*** Hearing Loss, Tinnitus & Mental Health https://www.actiononhearingloss.org.uk/mentalhealth.aspx
*" https://www.england.nhs.uk/wp-content/uploads/2016/07/HLCF.pdf
^ https://www.cobseo.org.uk/british-tinnitus-association/
Current and planned activity: 
The Tinnitus Clinic is supporting the grants department of the Royal British Legion by raising awareness of access to the Hearing Fund for individuals with a military background whose tinnitus could benefit from treatment from Levo Therapy System.

The Tinnitus Clinic would welcome discussions with either military rehabilitation providers, CCG’s or Primary Health Care to test the use of Levo Therapy in their locations.

ROI would be with new patients within the first 6 months but could also be introduced as a disruption to current patients on treatment, allowing savings to be implemented even with patients further along the care pathway.
What is the intellectual property status of your innovation?:
Product Manufacturer Otoharmonics has two issued patents in the US and these patents are in the European National Phase Application No. 14818503.6.  Additionally, Otoharmonics has a patient pending for “Wireless Audio Device”.  “Levo” and “Otoharmonics are also Trademarked in the UK/EU.
Levo System is CE Mark Class IIa approved.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Regional Scalability:
The Levo Therapy is currently only available in the private sector. Ideally, we would like tos cale up by providing the treatment to NHS audiology departments, or primiary care practices with community audiologists. 
Measures:
Quality: CE and FDA approved QM systems ensure device quality. Patient experience is gathered through surveys and completion of Tinnitus Fuinctional Index questionnaires at the start and completion of treatment
Safety:  Safety is the role of the FDA and CE registration and we comply with manufacturers requirements for reporting adverse incidents , of which we have had none. 
Cost: The Levo Therapy costs £3995 inclusive of VAT in the private sector but this would not be cost price to an NHS commissioner
People: Quality of Life measures using the TFI recording. Suibjectgive measures during follow up appointments 
Adoption target:
The Levo Therapy is available privately and we would welcome the opportunity to provide this system to severe or catastophic patients within the NHS syetem, who are suitable for this treatment and have not responded to current NHS treatments. 
Read more
Hide details
Josephine Swinhoe 26/04/2017 - 10:21 Detailed Submission Login or Register to post comments
6
1
Votes
-99999
Innovation 'Elevator Pitch':
MIRA is a software application designed to make physiotherapy fun and convenient for patients in need of rehabilitation. It turns physical exercises into video-games and uses Microsoft Kinect to track and assess patient treatment compliance.
 
Overview of Innovation:
Physiotherapy and rehabilitation can be a long, difficult and sometimes painful process. Treatment plans can be cumbersome and a slow recovery can be disempowering for patients. 70% of patients do not adhere to home exercises, which increases the total time needed for recovery, leading to higher costs for the healthcare sector.

MIRA displays these exercises as video-games and asks patients to complete the recommended movements to progress through each game level. As a result, patients are playing, while at the same time actually recovering. The patient’s performance data is also tracked, storing all the repetitions, improvements or issues for the therapists to adapt the treatment accordingly. As each patient and their treatment require careful planning, MIRA is designed as a tool for the therapists, to enable specialists to customise the treatment for each individual. Our innovative software can be tailored to the patient’s condition, needs and goals (stroke, falls prevention, MSK disorders etc.), using off-the shelf hardware (laptop/PC and motion sensor).

The software application is registered as a Class I Medical Device in Europe (CE Mark) and can be installed in any clinical environments where patients go for their regular treatment sessions, as well as at home where patients can be remotely monitored by their therapists. This allows the patient to exercises at home under the remote supervision of a healthcare provider. Furthermore, MIRA reduces costs by supplementing staff and reducing waiting times, as well as by decreasing the necessary number of clinic visits and the travel costs associated to them.

The system runs on Windows PCs, using Microsoft Kinect, a mainstream motion capture camera, to engage and track patients throughout their treatment.

MIRA Rehab has 14 UK institutions and another 44 worldwide, helping 600 patients monthly.  The youngest patient to have ever used the system was 3 years old, while the oldest is 102. MIRA was recently featured on BBC, as well as on TED.com in 2015.












www.mirarehab.com

Video links:
MIRA – Play your way to recovery
MIRA – Helping older people regain their mobility
 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Wealth creation / Clinical trials and evidence / Digital health / Person centred care
Benefit to NHS:
The primary benefits to NHS provided by using MIRA are mostly related to health outcomes, efficiency & cost effectiveness. Thus, MIRA can:
  • Supplement staff shortage and reduce waiting times, by enabling more patients to be treated at the same time at the clinic as well as remotely supervised at home
  • Reduce recovery time for a large group of patients by increasing motivation for the adherence to treatment through an interactive and engaging exergaming tool
  • Reduce costs associated to travel by decreasing the necessary number of visits to the clinic
  • Prevent further injury or surgery and thus reduce important costs associated to further hospitalisations and treatment caused by lack of compliance to the initial treatment
 
Quotes from NHS clients
"The [MIRA] concept is that it will replace me, as the clinician, or the therapist who is going to do the exercises with the patient. Not for all of the time, but for a part of the time. So it will supplement what we do and it will also improve patient care because patients will do it better based on the principles of gamification. When I describe it to people, people just go Wow! If this continues, it will change the way modern medicine is practiced"
Mr Bibhas Roy,
Shoulder and Elbow Surgeon, Central Manchester NHS Foundation Trust 
               
“There is huge potential. I give a lot of talks to older people and they are very interested…There is a great need there. You can have a lot of patients using the exergames at home with the physio reviewing and keeping an eye. With the data that is remotely sent to the clinic you can very easily see if individuals are complying, improving, and if they are not improving whether they need a visit.
Emma Stanmore,
Lecturer in Nursing, The University of Manchester
 
“Many individuals over the age of 65 haven’t played computer games before, but those who have been helping us test the technology have given us very positive feedback.”
Emma Stanmore,
Lecturer in Nursing, The University of Manchester
 
 “MIRA is an innovative product that could alter the way therapy is delivered to patients in the future. It has the potential for patients to be more active in their rehabilitation, which should result in improved patient and service outcomes.”
Mark McGlinchey,
Clinical Specialist Physiotherapist, Guy’s & St. Thomas’ NHS Foundation Trust
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
Benefits for WM
  • An innovative tool that offers the possibility to have a better supervision of their patients, better medical outcomes and a more competitive practice
  • Created based on the best available clinical evidence (ex. Falls prevention exercise package) and validated in clinical trials
  • Net average saving associated with the use of Exergames for falls prevention would be £1,202 per patient per year for one MIRA unit (Health Economic Report by JB Medical)
  • The clinic can offer MIRA as a separate therapy service, developing a new business opportunity, improving treatment and physiotherapy services delivery (like reducing waiting times)
  • MIRA allows them to track patients’ compliance and progress at home
  • Reduce readmission and costs associated to further treatment and hospitalisation due to non-adherence to initial prescribed therapy (ex. Home exercises are more likely to be done if patients are being checked and if they have an engaging tool.
  • Specific therapy plans for patients can be prescribed from any location, and  it offers a suit of customisable exercises and games that therapist can easily tailor as they see fit for their patients
  • Possibility to monitor and engage more patients at the same time
  • Based on this modern instrument with its data gathering feature, therapists can access new research opportunities, important movement data and statistics that were not easily available before
  • Patient data is safe – data protection and security regulations have been carefully implemented to ensure best protection and security measures required have been implemented
Benefits for its population
  • An attractive environment through gamification engages patients to perform the prescribed exercises and comply with their treatment avoiding further complications and reducing recovery time
  • A new, easy and fun way to interact with rehabilitation or therapy
  • Patients can continue exercising in between clinic sessions being guided and supervised by a medical specialist, keeping a closer contact with the clinicians
  • Based on occupational therapy MIRA distracts the patients’ suffering and focus on pain while exercising
  • Increase the quality of patients’ life and of their families
  • When they cannot attend the therapy sessions MIRA is an efficient tool and fast way to perform the prescribed treatment plans at home
Current and planned activity: 
Current NHS Engagement:
1. Central Manchester University Hospitals NHS Foundation Trust (CMFT)
2. Guy's and St. Thomas' NHS Foundation Trust (GSTT)
3. Epsom and St Helier University Hospitals NHS Trust (ESTH)
 
Planned Activities/Upcoming:
Five other NHS organisations are in the process of implementing MIRA in their treatment delivery;

MIRA is a platform created to support extensions with new packages targeting new types of rehabilitation (hand fine movements, aerobics, speech therapy, etc.). Thus, we are willing to engage with clinical partners for clinical input, studies and validation on the development of the new modules. 

(See attached NHS Engagement document for further details)
 
What is the intellectual property status of your innovation?:
No patent on product as it is a software product (trade secret). We have full copyright of the software and source code of the application.

We are in the process of registering the MIRA trademark.
Return on Investment (£ Value): 
Very high
Return on Investment (Timescale): 
1 year
Ease of scalability: 
3
Read more
Hide details
Cosmin Mihaiu 11/04/2017 - 15:53 Publish Login or Register to post comments
6
4
Votes
-99999
Innovation 'Elevator Pitch':
Integrate with PAS and rostering systems, to bring together capacity and demand; automating manual processes used to judge which staff ought to be scheduled to which patient appointments with dynamic rescheduling throughout the day via mobile app.
Overview of Innovation:
NHS community services are one of the last industries to adopt an automated and intelligent appointment scheduling system to help manage their field based (community healthcare) staff. Significant improvements can be made in the way community workforce are managed by optimising the patient appointment booking (scheduling) process.

Initial research indicates that there are few Trust with systems in place to effectively and efficiently schedule which staff should visit which patients at which times. Our objective is to work with NHS Community Trusts to develop MISS (Malinko Intelligent Scheduling System) to systemise the current informal and ad-hoc processes used to do this.

Malinko is a scheduling system with mobile app to allow staff to check in and out of visits which is already used in other sectors.  It requires some additional work to ensure that it works well for the healthcare sector.  These elements are:
  • Integration with the PAS (Patient Administration System) to bring in patient appointment requirements and with the rostering system to for staff capacity.  By taking this information, along with predefined parameters based on provided KPIs, Malinko’s scheduling algorithm will ensure that the rostered staff attend the optimal visits.
  • Mobile app to enable staff to communicate live back to the main system any issues that would result in their visits to require rescheduling that day. The Malinko system would then automatically reschedule these and let any affected staff know. 
  • The office staff have a live nurse tracker board, enabling them to see last known locations of all nurses out in the field.
  • The nurse can send a text message or voice message to the patient to let them know they were on their way to avoid DNAs (Did Not Attends).
This would enable substantial productivity gains and cost reductions within NHS community services with marked reductions in non-clinical contact time as Nurses on average spend 19% time in administration includes office visits. It would also result in significant service improvements being achieved as it would allow community nurses to both spend more valuable time with patients and enable them to see more patients.  In turn, we would expect to see a reduction in acute activity and pressures.  Additionally, by optimising the appointment booking process there is an opportunity for NHS Community services to make direct cost savings in area’s such as travel, administration, staffing and the costs associated with DNAs.

Stage of Development:
Evaluation stage - Representative model or prototype system developed and can be effectively evaluated
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Digital health / Innovation and adoption
Benefit to NHS:
Integration with the PAS and the staff rostering system into the MISS to intelligently create the appointment schedules has a whole range of benefits for the NHS provider and patients.  In summary:
  • Improve caseload management using skills, knowledge and training to best effect.
  • Help release and focus capacity due to ‘live’ organisation wide view of demand and capacity.
  • Reduces time in morning meetings at start of day as these can be electronically received by staff.
  • Automatically scheduling based on an algorithm, reducing staff scheduling time and leaving them to just approve and make manual alterations to this schedule.  
  • As referrals come in during the day, they are automatically added and scheduled dependent upon priority.  If they require a visit within the day, the system will automatically add the job onto the most efficient round and dynamically reschedule other appointments effected.
  • Route optimisation, reducing time spent travelling and cost of travel.
  • Automatic mileage expense claims based on these routes.
  • Release time to care improving patient and staff experience.
  • Patient feedback mechanism to report satisfaction with the service.
  • Analysis of patient/community nurse combinations - eg where a patient dislikes a particular nurse and so is regularly out for their visits
  • Ability to send telephone and text alerts to patients reducing likelihood of DNA and leading to improved timeliness of visits including administration of medicines. This will also result in giving patient a narrower window of likely nurse arrival.
  • Ensure prioritisation of patients that need to be seen today and those that can be deferred.
  • Ability to redirect workforce to high risk patients in an emergency, therefore preventing admissions.
  • Ability to provide continuity of care as system logs number of previous visit during allocation process.
  • Benchmarking performance across the team members or indeed whether the team as a whole is underperforming against an external benchmark with full visit history for each patient and by each staff member. Spot trends and improve resourcing.  Examples include identifying where a patient doesn’t like a particular nurse and so is regularly out for their visits, or to quickly identify training needs where staff are regularly underperforming for particular types of visits.
  • Lone worker risks prevented with mobile app and nurse tracker board.  Silent panic alarm button within the app can send to office or escalate to emergency services.
Initial Review Rating
4.20 (1 ratings)
Benefit to WM population:
MISS can help the NHS to deliver better care at a lower cost by freeing up capacity to meet ever increasing demand.
 
Based on in-depth research on site with 4 NHS Trusts, West Midlands NHS Community Service providers can reduce the following by deploying the MISS:
 
Reduce senior nursing non-clinical contact time: It is forecast a service/locality with 20 FTE staff, with one locality manager and two senior triage nurses, could reduce 109 hrs/month of senior nursing non-clinical contact time by automating the patient allocation process with MISS (3.6 hrs per day of senior nursing time 7 days per week; service running at 50% at capacity the weekend).
 
Reduce Community Nursing/HCA non-clinical contact time: It is forecast a service/locality with 20 FTE staff and 16 community nurses/HCAs could reduce 416 hrs/month of non-clinical contact time (1 hour a day per nurse - 7days a week; service running at 50% capacity at the weekend).
 
Reduce DNA rates by 50%: Although one Trust we have worked with reported a DNA rate of 10%, we have little hard data with regard to current DNA rates and the cost of each DNA to the Trust, the view is DNA rates could be significantly reduced by adopting MISS’s integrated automated patient appointment reminder system (text and voice calls). Other NHS Trusts have analysed how much each DNA costs, reporting an average of £80 per DNA. Reducing DNAs would also have a significant impact on improving the efficiency of the service/locality and reducing patient complaints.
 
Other potential cost savings include (more detailed analysis required): Overtime; Bank and Agency; Travel; DNA; Replace incumbent standalone lone worker system in two of the Trusts; Replace current standalone expenses system; Admin.
Current and planned activity: 
Nov 15: 1st NHS customer 

Nov 16: Agreement from GM NHS Trust to deploy MISS in their District Nursing service across 6 localities and their District Nursing evening service, pilot funded by the GMAHSN Momentum bid. 

Dec 16: Other pilot start; deploy MISS in their District Nursing service in two localities.

There are a number of other NHS organisations who are interested in MISS.  We are looking for further pilots or early adopter profile Trusts, which due to recent funding we are able to part fund internally.

We would like introductions to (Deputy) CIO or (Deputy) DOF roles within West Midlands and nationwide to NHS Trusts which provide community services, including mental health.
What is the intellectual property status of your innovation?:
The IP is held within Liquid Bronze.
Accredited with Information Governance
Accredited with ISO27001
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
2 years
Ease of scalability: 
Simple
Read more
Hide details
Antony Quinn 20/01/2017 - 16:49 Publish Login or Register to post comments
4
1
Votes
-99999
Innovation 'Elevator Pitch':
Rally Round helps frail and vulnerable adults to live well at home. It also helps patients recover from illnesses and other health challenges. See  www.rallyroundme.com
Overview of Innovation:
What Is It?
Rally Round is an easy to use secure social networking tool that allows family members, friends and carers to easily create and organise support for someone they care about.
 
Core Features
A support network account is created and other trusted family members, friends and carers are invited to join. Everyone adds support tasks that need doing, such as shopping, help with transport, socialising etc. Network members choose which tasks to help out with. 


Text and email alerts remind everyone what needs doing, who is doing what and when things need to be done. 
Important information can safely be shared with other members of the support network via the Noticeboard.


Rally Round can be offered to people in 3 ways:
 
Self Service: social media marketing and off line promotion drives local people to a bespoke Rally Round website landing page. From here people can create and build up support networks themselves.
 
Assisted Networks: NHS Staff (plus partner organisations and third sector organisations) refer people to Rally Round via an online referral dashboard. Referrals made instantly trigger an automatic email and phone based onboarding service provided and run by Rally Round.

Managed Networks:  NHS Staff (plus partner organisations and third sector organisations) are trained and supported to introduce Rally Round to relevant clients and/or families of clients. They do this via a managed networks login that allows networks to be created very efficiently. Staff who use this process are automatically assigned to be the coordinator of the networks they create. In this way they can build up the support network by issuing invitations to family members, friends or volunteers before leaving.  

Social Capital and Performance
 
Licence holders have access to a Data Dashboard. This lists all the networks associated with their licence together with key performance data e.g. number of helpers in each network, number of support tasks moving through a network and the resilience of each network as measured by the way in which support tasks are shared amongst network helpers. In essence the Data Dashboard provides a glimpse into people’s social capital. 









 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Digital health / Innovation and adoption
Benefit to NHS:
 Benefits to NHS organsiations:
  1. Strengthen prevention and self-care strategies
  2. Defer demand for GP and other primary care services
  3. Speed up discharges from community rehab / step-down facilities
  4. Support recovery of some MH clients 
  5. Defer or reduce volume and cost of carer breakdowns
Benefits to Local Authorities:
  1. Strengthen prevention and self-care strategies
  2. Defer demand for funded social care support
  3. Extend reablement support by utilisation of family members and friends
Initial Review Rating
4.20 (1 ratings)
Benefit to WM population:
Benefits to vulnerable persons / patients / clients:
  1. Remain living well and independently in own home for longer and/or recover better
  2. Receive more practical and timely support from carers, friends and family members
  3. Reconnection with more friends and relatives
  4. Reduced loneliness and social isolation
  5. Improved quality of life
Benefits to carers, family members and friends
  1. Less 'burn-out' / more practical help on a day to day basis
  2. Enhanced ability to remain in or return to paid employment
  3. More time freed up for pursuit of own interests
  4. Ability to offer help, even if physically distant
  5. Peace of mind, through access to the dashboard information, that a loved one is getting timely support.
Current and planned activity: 
Several Local Authorities and third sector organisations already use Rally Round, including Essex County Council, Bradford MDC and Bolton Council. We are now keen to work with NHS organisations to explore the potential for Rally Round to be offered systematically to patients to help achieve a range of demand deferral, prevention, self-care, discharge and recovery goals. 
What is the intellectual property status of your innovation?:
Rally Round has been created by Health2Works Ltd. As such we own and control use of all software code.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
2 years
Ease of scalability: 
Simple
Read more
Hide details
Steve Pashley 17/01/2017 - 12:38 Publish 2 comments
6
2
Votes
-99999
Innovation 'Elevator Pitch':
SMC provides an innovative, integrated, digital platform solution that deliver better patient outcomes, greater self-management and delivers healthcare more efficiently. The system is highly configurable and customisable and deployable at scale.
Overview of Innovation:
SPS have created an open, future proofed digital platform that harnesses and integrates a range of mobile, communication and wearable technologies to pre-emptively and pro-actively support improved patient outcomes while enabling more efficient healthcare service delivery across primary, secondary and social care environments.
Our mobile health (mHealth), telemedicine and telecoaching solutions use familiar mobile and ‘cloud’ based technology. It has been proven to  support service redesign and deliver more efficient, patient centric healthcare that’s cost effective, simple to use and easy to implement at scale.
Our ‘open’ architecture and web based platform enables more holistic Long Term Condition management services by leveraging a range of technologies across mobile, tablet, text, video and voice to deliver a highly flexible solution for healthcare professionals and patients. Mobile health (mHealth) enhances patient outcomes by enabling clinicians to pro-actively and pre-emptively monitor patients remotely while also enabling the individual to better understand and manage their condition that results in improved patient outcomes, reduced visits to hospital and local GP’s Surgeries.
Our SMCTM solution can be customised to meet any Long Term Condition (LTC), co-morbidity or medical condition that an individual may suffer from. It can support one or multiple LTCs, as well as any other health or mental health condition where a question or vital sign measurement can be of benefit. To date core commissioning has been focused on supporting people who suffer from Heart Failure, Coronary Heart Disease, Hypertension, Chronic Obstructive Pulmonary Disease, Asthma and Diabetes, but we have also developed profiles to support Urinary Tract Infection, Falls Prevention, Dementia and Depression management, Cystic Fibrosis, Obesity and end of Life.
The SMCTM solution is deployed across multiple CCG’s and provider in the UK with over 10,000 patients benefiting from the system over the past 5 years. We have supported different operational and clinical pathways, including effective system deployment into patient homes and Care Home environments that can then enable pro-active and pre-emptive alerts to be raised with a Clinical care team.  Our technology and services have also been selected by a wide range of organisations including BT Health, Alere, Welch Allyn, MSD Commercial, Healthcare @Home to support new and existing service models in the field of telehealth.
 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Education, training and future workforce / Wealth creation / Clinical trials and evidence / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
Key deliverables achieved with SMCTM solution:
  • Facilitate early patient discharge and reduce bed days: Harrow CCG, 2014: achieved a 50% reduction in unplanned admissions and 63% bed day reduction to deliver an ROI of 159% and net savings of £3,444 per COPD and cardiac patients.
  • Improve prevention and early intervention:  Derbyshire Community Hospital, 2014: achieved a 68% reduction in unplanned admissions; 415 bed day reduction across 187 patients in a 6 month period with a net saving of c£100,000.
  • Improve service value and efficiency of service provider: Bristol CCG, 2013: within just 30days of the telehealth service starting the number of contacts reduced by 26% with an 18% reduction in face to face time and 40% reduction in telephone contacts
  • Sustain independent living and improve patient outcomes: Birmingham Community Health, 2014: Surveyed 312 patients with 86% of patients stating system helped them manage their condition; 84% more involved in their care; 90% happy to reduce the number of routine hospital visits.
     
Initial Review Rating
4.20 (1 ratings)
Benefit to WM population:
SMC offers multiple benefits for patients:
  • Personalised care modules: supports an individual's care needs using the most relevant questionnaires, vital signs and content.
  • Embedded educational content: on demand video aids training, behaviour change, understanding and the confidence for patients to self-manage their condition.
  • Sustains independent living: the use of relevant, integrated and familiar technology empowers patients to better understand and manage their conditions at home.
  • Easy to use and "out of the box": use fo familiar smartphones and tablets with wireless peripherals; audio and multi-lingual options.
  • Remote access and support software: touchscreeen enabled device support over the phone.
  • Video tele-consultation: remote "face to face" clinical consultation to aid better clinical intervention.
  • Text messaging: enable cost effective self-care.
  • Better patient outcomes: improves quality of life, reduces anxiety and increases confidence.
Current and planned activity: 
The SMC solution is deployed across multiple CCG’s and provider in the UK with over 10,000 patients benefiting from the system over the past 5 years. We have supported different operational and clinical pathways, including effective system deployment into patient homes and Care Home environments that can then enable pro-active and pre-emptive alerts to be raised with a Clinical care team.   Our technology and services have also been selected by a wide range of organisations including BT Health, Alere, Welch Allyn, MSD Commercial, Healthcare @Home to support new and existing service models in the field of telehealth.
We have long standing partnerships with Somerset CCG, Cornwall Foundation Trust Rotherham NHS Foundation Trust, and Dudley CCG and have been awarded innovator partnership on two Test Beds, one in Surrey and one in Manchester (with MSD Commercial.)

We support other conditions and pathways: Cystic Fibrosis, Falls and UTI, Spina Bifida children, LTC6 and E5QD quality of life.
Return on Investment (£ Value): 
N/A
Return on Investment (Timescale): 
N/A
Ease of scalability: 
Simple
Read more
Hide details
Elisabeth Barbosa 12/01/2017 - 16:57 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
GroundVision provides the next generation of patient observations, and a range of dashboards, including our specialised Rapid Detection and Response (RADAR) view, to enable an efficient, proactive response to the deteriorating patient.
Overview of Innovation:
Over 6,000 people die every year in hospital as a result of “failing to rescue” a deteriorating patient. GroundVision provides a simple and cost effective system to record and calculate EWS (Early Warning Score) and a variety of other observations and assessments, from Bristol Stool to Fluid Balance, at the patient bedside to ensure that deteriorating patients are quickly and accurately identified.

As well as the ability to record patient observations at the bedside, GroundVision provides a variety of specialised views for different departments of a hospital:

Ward View
Displays information and observations about all patients on a ward.
 
Critical Care View
Displays information and observations about all patients in the Trust, with filtering capabilities, enabling searches for groups of patients (e.g. those that are deteriorating).
 
Infection Control View
Displays information about Bristol Stool Samples and infectious patients, enabling better control of infection outbreaks.
 
Ops Team View
Displays all side rooms in the hospital, with information about their occupancy, including a reason and priority for the isolation of a patient.
 
Dashboard View
Allows users to create customisable reports/graphs about a wide range of patient and observation related information.
 
RADAR (Rapid Detection And Response) View
Provides a view that shows all deterioration patients within their “score banding” who have not been responded to. The solution also graphically shows their health trajectory enabling healthcare staff to intervene before the patient triggers. This real-time view can be displayed via tablet, desktop or electronic whiteboard onsite or remotely.

Our solution has been developed alongside nurses, so it is easy to use as well as being low cost. It can be used on any device and accessed remotely as well as on site.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Digital health / Patient and medicines safety / Person centred care
Benefit to NHS:
GroundVision can provide a variety of benefits to the NHS:
  • Reduction in patient mortality
  • Reduction in hospital length-of-stay
  • Reduction in time taken to record/calculate Obs/EWS
  • Improvement in the accuracy of EWS calculations
  • Increased levels of clinical attendance
  • Increase compliance with hospital protocols
  • Reduction in the number of unexpected cardiac arrests
  • Fewer admissions to ICU
  • Reduction in the number of ICU days
  • Reduction in the number of infection outbreaks
As well as this, it brings the NHS one step closer to being paperless.
Initial Review Rating
3.80 (1 ratings)
Benefit to WM population:
It can help NHS organisations within the West Midlands area by improving patients safety and patient outcomes.
Current and planned activity: 
We have been engaged with Surrey and Sussex Healthcare NHS Trust, co-developing our solution alongside them and providing pilot projects, rolling out our solution to several wards.

We are also currently engaged with other NHS organisations within that area, such as Kent Community Healthcare NHS Foundation Trust.

We will continue to engage with as many NHS organisations as we can as well as continuing to develop our solution, to increase the wealth of observations and assessments that we have available to contribute towards improving patient safety.
What is the intellectual property status of your innovation?:
Simply Clever Ltd (trading as GroundVision) own the intellectual property 100%
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
3 years +
Ease of scalability: 
2
Read more
Hide details
Anonymous 12/01/2017 - 16:24 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
More people die of SUDEP (Sudden Unexpected Death in Epilepsy) than in house fires every year.
 
Every home has smoke detector, so why shouldn’t all epileptics have a device that alerts people close by so that they can provide assistance when needed?
Overview of Innovation:
Embrace is the world’s 1st system for seizure detection based on analysing multiple physiological data sensed at the wrist.



Should someone with Epilepsy experience an ‘unusual event’, such as a convulsive seizure, an alert will be sent via their smartphone to parents, friends or caregivers, summoning immediate help. Additionally, a caregiver can also wear a 'companion' Embrace. When the two Embraces are within range (e.g. in nearby rooms), the 'companion' Embrace worn by the caregivers will vibrate to alert them.

The Embrace watch has received awards for its design & innovative technology. The watch monitors Electrodermal Activity (EDA), also known as Galvanic Skin Response (GSR), which is autonomic data that is activated by regions deep in the brain involved in emotions such as fear, anxiety & excitement.
 
Embrace watch also functions as a sleep monitoring & activity tracking device.
 
What else do Embrace sensors monitor?
Embrace comes with an app called Mate. Mate combines events that are entered manually with events that are sensed by Embrace. Mate helps see how patterns of sleep, autonomic stress, skin temperature and physical activity may interact with seizure events. (NB: initial release of Mate app features rest and activity information, while features like autonomic stress monitoring, are still in development and will be added later). For example, if there are an increased number of absence seizures when stress levels have been high and sleep has been irregular, then these can be tracked to see if changing these patterns reduces the number of seizures.
 
Embrace and Alert app system for seizure detection is for investigational use only. The system is currently not clinically proven to detect seizures. Evidence of seizure characterization using the technology in Embrace has been gathered in a number of clinical trials since the initial discovery of skin conductance changes during a seizure was published in 2012. Empatica is currently conducting clinical trials to evaluate seizure detection of generalised tonic clonic seizures (GTCS) using the Embrace watch & Empatica Alert app.
 
The automatic physiological data logging provided by the Embrace system is valuable when someone experiences a seizure as they may not remember what has happened themselves. A diagnosis is often based on finding out what happened to the individual before, during and after a seizure.
 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Wealth creation / Clinical trials and evidence / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
The number of people in the UK diagnosed with epilepsy has risen sharply in recent years. There are around 65 million people living with epilepsy in the world, with an estimated 600,000 people in the UK.
 
Every day in the UK, 87 people are diagnosed with epilepsy. Only 52% people with epilepsy in the UK are seizure-free.
 
During 2013, 1,187 people in the UK with epilepsy died earlier than expected (premature death). Some of these deaths could have been prevented. A clinical audit of epilepsy deaths in 2002 found that 64 per cent of adult deaths and over half of child deaths were possibly or probably avoidable.
 
Epilepsy is misdiagnosed in 20-30% of cases: most commonly, non-epileptic conditions are incorrectly diagnosed as epilepsy. Up to 40% of children referred to a tertiary clinic do not have epilepsy.  In 2004, the National Institute for Clinical Excellence (NICE) estimated the direct costs of epilepsy misdiagnosis (including inappropriate treatment, but not including individuals’ lost productivity from misdiagnosis) to be between £130m and £190m per year (NICE (2004) Epilepsy, second consultation, Appendix G).
 
Limiting the rate of misdiagnosis will help to reduce the risk of teratogenicity in wrongly diagnosed patients and will prevent patients wrongly diagnosed with epilepsy from facing, for example, unnecessary restrictions in employment and in other areas of life. Better diagnostic services are also likely to reduce any treatment gaps or inequalities, and, through encouraging independent living, improve the rate of employability for people with epilepsy. Finally, patients will have a greater choice of treatment options and a greater sense of empowerment
 
Epilepsy is an ambulatory-sensitive condition, meaning that better management in the community or primary care setting can effectively avoid unnecessary visits to the emergency department and non-elective hospital admissions.
 
Prevention of 15 admissions to hospital would Save the salary of a single epilepsy nurse
Estimate from National Audit of Seizure Management in Hospitals 2 (NASH2)
 
In 2009, there were 13 million prescription items of anti-epileptic drugs dispensed in the community in England, at a net ingredient cost of £300 million (NHS Information Centre Prescription Cost Analysis 2009. The net ingredient cost is the cost of the drug before discounts, not including any dispensing costs of fees).
Initial Review Rating
4.60 (1 ratings)
Benefit to WM population:
Epilepsy affects 54,000 people in the West Midlands (Source Birmingham City Council May 2016). The economic and social costs of managing this cohort is very significant.
 
Gaining control of one’s epilepsy not only saves direct health related costs in terms of fewer emergency or longer term hospital admissions, but also enables individuals with epilepsy to continue working and maintain their independence.
Current and planned activity: 
Current activity:
The Embrace device was only recently launched in the UK in November 2016. Currently clinical trials are taking place in the USA.
https://support.empatica.com/hc/en-us/sections/200817625-Seizure-Characterization-Clinical-Trial-monitoring-with-Embrace
 
We have taken orders from a number of Local Authority Assistive technology departments and are keen to engage further with the NHS.

Planned/future activity:
The published trial results cited above were from predicate devices. We need to collect more data using the Embrace and Alert app to complete the medical and FDA certification processes before we are able to make any claims regarding seizure detection performance of this system.
 
We are very keen to work more closely with any West Midlands network that provides support to people with Epilepsy or Autism.
 
What is the intellectual property status of your innovation?:
Patents Held by Empatica – further info available upon request.

The device is currently being fast tracked through FDA approval.

It also holds - Certifications:  CE Mark, FCC CFR 47 Part 15,  RoHS.
Return on Investment (£ Value): 
Very high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Read more
Hide details
Ben Carter 19/12/2016 - 12:34 Publish Login or Register to post comments
0
0
Votes
-99999

Recent Activities

VideoVisit is a holistic digital outpatient care platform for healthcare professionals to deliver remote patient monitoring has been moved from Initial Submission to Publish 5 days 13 hours ago
Hospify has been moved from Initial Submission to Publish 6 days 19 hours ago
Clinical Research and Clinical Trial Collaborations has been moved from Initial Submission to Publish 2 months 1 week ago
The Real Birth Online Workshop: addressing the barriers to effective antenatal education has been moved from Initial Submission to Publish 2 months 1 week ago
Elaine Russell commented on Cera Care 2 months 2 weeks ago

Active Campaigns